Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm	Not yet recruiting	Phase 2	2024-08-26		NCT06569225

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hamilton Health Sciences Corporation	60
Sunnybrook Health Sciences Centre	193
University Health Network, Toronto	417

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Health Network, Toronto General Hospital	Toronto	Canada	6

Clinical trials